Theraclion is a leading company in the development of innovative medical devices for the non-invasive treatment of solid tumors. With a focus on ultrasound technology, Theraclion provides solutions for the treatment of thyroid nodules and breast fibroadenomas, offering patients a non-surgical alternative with minimal downtime and side effects.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#2 in Malakoff

#1,852 in France

Malakoff, France

Theraclion

Forward Citations = 2

7 inventors:

Francois Lacoste (5 out of 28 patents)

Thierry Pechoux (4 out of 13 patents)

Sylvain Yon (2 out of 4 patents)

4. François Lacoste (2 out of 3 patents)

5. Roberta Brocardo (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Theraclion. Retrieved from https://idiyas.com/company/theraclion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

9 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]